Serum ghrelin level is associated with cardiovascular risk score

1. GARCÍA EA, KORBONITS M. Ghrelin and cardiovascular health. Curr Opin Pharmacol. 2006; 6 (2):142-7.10.1016/j.coph.2005.10.00616483844Search in Google Scholar

2. TESAURO M, SCHINZARI F, CARAMANTI M, LAURO R, CARDILLO C. Metabolic and cardiovascular effects of ghrelin. Int J Pept. 2010; 6:62-70.Search in Google Scholar

3. BROGLIO F, PRODAM F, ME E, RIGANTI F, LUCATELLO B, GRANATA R, BENSO A, MUCCIOLI G, GHIGO E. Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest. 2005; 28(5 Suppl):23-5.Search in Google Scholar

4. The Lipid Research Clinics Coronary Primary Prevention Trial Results I. Reduction in Incidence of Coronary Heart Disease. JAMA. 1984; 251:351–64.10.1001/jama.251.3.351Search in Google Scholar

5. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem. 1972; 18:499–500.10.1093/clinchem/18.6.499Search in Google Scholar

6. LOTT JA, TURNER K. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem. 1975; 21:1754–60.10.1093/clinchem/21.12.1754Search in Google Scholar

7. ESH/ESC TASK FORCE FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION. 2013. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013; 31(10):1925-38.10.1097/HJH.0b013e328364ca4c24107724Search in Google Scholar

8. https://escol.escardio.org/Heartscore/calc.aspx?model=europehigh.Search in Google Scholar

9. CUMMINGS DE, PURNELL JQ, FRAYO RS, SCHMIDOVA K, WISSE BE, WEIGLE DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001; 50(8):1714-9.10.2337/diabetes.50.8.171411473029Search in Google Scholar

10. POYKKO SM, KELLOKOSKI E, HORKKO S, KAUMA H, KESANIEMI YA, UKKOLA O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes. 2003; 52(10):2546-53.10.2337/diabetes.52.10.254614514639Search in Google Scholar

11. ZHANG M, FANG WY, YUAN F, QU XK, LIU H, XU YJ, CHEN H, YU YF, SHEN Y, ZHENG ZC. Plasma ghrelin levels are closely associated with severity and morphology of angiographically-detected coronary atherosclerosis in Chinese patients with diabetes mellitus. Acta Pharmacol Sin. 2012; 33(4):452-8.10.1038/aps.2011.196400336522367281Search in Google Scholar

12. ZHANG M, FANG W, YUAN F, QU X, LIU H, CHEN H, YU Y, ;ZHENG Z, SHEN Y. Plasma ghrelin levels are closely associated with stenosis severity and morphology of angiographically-detected coronary atherosclerosis in patients with coronary artery disease. Int J Cardiol 2011; 151(1):122-3.10.1016/j.ijcard.2011.06.03121704395Search in Google Scholar

13. YANG D, LIU Z, LUO Q. Plasma ghrelin and pro-inflammatory markers in patients with obstructive sleep apnea and stable coronary heart disease. Med Sci Monit2013; 19:251-6.10.12659/MSM.883874365915523567762Search in Google Scholar

14. YOSHINAGA M, TAKAHASHI H, SHINOMIYA M, MIYAZAKI A, KURIBAYASHI N, ICHIDA F. Impact of having one cardiovascular risk factor on other cardiovascular risk factor levels in adolescents. J Atheroscler Thromb. 2010; 17(11):1167-75.10.5551/jat.526420808052Search in Google Scholar

15. YANO Y, NAKAZATO M, TOSHINAI K, INOKUCHI T, MATSUDA S, HIDAKA T, HAYAKAWA M, KANGAWA K, SHIMADA K, KARIO K. Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. Am J Hypertens 2014; 27(5):727-33.10.1093/ajh/hpt23224363280Search in Google Scholar

16. HAMED EA, ZAKARY MM, AHMED NS, GAMAL RM. Circulating leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative stress. Diabetes Res Clin Pract. 2011; 94(3):434-41.10.1016/j.diabres.2011.08.02321924513Search in Google Scholar

17. RODRÍGUEZ A, GÓMEZ-AMBROSI J, CATALÁN V, BECERRIL S, SÁINZ N, GIL MJ, SILVA C, SALVADOR J, BARBA J, COLINA I, FRÜHBECK G. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens. 2010; 28(3):560-7.10.1097/HJH.0b013e328334327c19907342Search in Google Scholar

18. UKKOLA O. Ghrelin and metabolic disorders. Curr Protein Pept Sci. 2009; 10: 2-7.10.2174/13892030978731522019275667Search in Google Scholar

19. VESTERGAARD ET, GORMSEN LC, JESSEN N, LUND S, HANSEN TK, MOLLER N, JORGENSEN JO. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 2008; 57(12): 3205-10.10.2337/db08-0025258412518776138Search in Google Scholar

20. ZHANG G, YIN X, QI Y, PENDYALA L, CHEN J, HOU D, TANG C. Ghrelin and cardiovascular diseases. Curr Cardiol Rev. 2010; 6(1):62-70.10.2174/157340310790231662284579621286280Search in Google Scholar

21. POYKKO SM, KELLOKOSKI E, HORKKO S, KAUMA H, KESÄNIEMI YA, UKKOLA O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-53.10.2337/diabetes.52.10.254614514639Search in Google Scholar

22. POYKKO S, UKKOLA O, KAUMA H, SAVOLAINEN MJ, KESANIEMI YA. Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 2003; 46: 455-8.10.1007/s00125-003-1058-z12739020Search in Google Scholar

23. UKKOLA O, PÄÄKKÖ T, KESÄNIEMI YA. Ghrelin and its promoter variant associated with cardiac hypertrophy. J Hum Hypertens. 2012; 26(7):452-7.10.1038/jhh.2011.5121614024Search in Google Scholar